This is a quick, cost-efficient protocol for the production of secreted, glycosylated mammalian proteins and subsequent single-step purification with sufficient yields of homogenous protein for X-ray crystallography and other biophysical studies.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
This is a quick, cost-efficient protocol for the production of secreted, glycosylated mammalian proteins and subsequent single-step purification with sufficient yields of homogenous protein for X-ray crystallography and other biophysical studies.
Production of secreted mammalian proteins for structural and biophysical studies can be challenging, time intensive, and costly. Here described is a time and cost efficient protocol for secreted protein expression in mammalian cells and one step purification using nickel affinity chromatography. The system is based on large scale transient transfection of mammalian cells in suspension, which greatly decreases the time to produce protein, as it eliminates steps, such as developing expression viruses or generating stable expressing cell lines. This protocol utilizes cheap transfection agents, which can be easily made by simple chemical modification, or moderately priced transfection agents, which increase yield through increased transfection efficiency and decreased cytotoxicity. Careful monitoring and maintaining of media glucose levels increases protein yield. Controlling the maturation of native glycans at the expression step increases the final yield of properly folded and functional mammalian proteins, which are ideal properties to pursue X-ray crystallography. In some cases, single step purification produces protein of sufficient purity for crystallization, which is demonstrated here as an example case.
Understanding protein structure at an atomic level is key to uncovering the molecular basis of biological pathways and diseases. X-ray protein crystallography is the most widely used/applicable method for determining macromolecular structures. The main challenge of this method is obtaining sufficient amounts of properly folded, pure protein. This becomes an issue particularly when working with secreted mammalian proteins, which undergo specific post-translational modifications.
Bacterially-expressed proteins are the primary source of crystallized proteins deposited in the Protein Data Bank1. Bacterial expression systems are large....
Access restricted. Please log in or start a trial to view this content.
1. Production of Milligram Quantities of Plasmid DNA for Large-scale Transient Transfection
Access restricted. Please log in or start a trial to view this content.
Herein follows the results of this expression system applied to a secreted 13 kDa immunoglobin (Ig) domain from the human protein triggering receptor expressed on myeloid cells 2 (hTREM2, residues 19-132). TREM2 is a type I transmembrane protein containing a single extracellular Ig domain that has two disulfide bonds and two N-linked glycosylation sites. Unlike many other Ig domain proteins8, TREM2 was not amenable to refolding from bacterial inclusion bodies9. Subsequent mutagenesis confirmed N-lin.......
Access restricted. Please log in or start a trial to view this content.
HEK 293F cells offer robust production of proteins requiring post-translational modifications. This system allows rapid and scalable expression of natively folded proteins containing disulfides, glycosylation, and phosphorylation that would otherwise be absent using more routine expression tools. In addition, this system can be used for the expression and purification of multi-protein complexes simply by co-transfection of multiple plasmids. Besides TREM2, this system has been extensively used for functional studies with.......
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing financial interests.
This work was supported by NIH R01-HL119813 (to T.J.B.), American Lung Association RG-196051 (to T.J.B.), a CIMED Pilot and Feasibility grant (to T.J.B.), American Heart Association Predoctoral Fellowships 14PRE19970008 (to Z.Y.) and 15PRE22110004 (to D.L.K.).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Culture Flasks | GeneMate | F-5909B | |
| 293 Freestyle Media | Gibco/Life Technologies | 12338-018 | |
| GlutaMAX | Gibco/Life Technologies | 35050-061 | Use in place of Glutamine |
| Hype 5 transfection reagent | Oz Biosciences | HY01500 | |
| 293fectin transfection reagent | Life Technologies | 12347019 | |
| PEI transfection reagent | Sigma-Aldrich | 408727 | |
| Maxiprep Kit | Qiagen | 12162 | |
| Ni-NTA Superflow | Qiagen | 30430 | |
| Endo Hf | NEB | P0703L | |
| Amylose Resin | NEB | E8021S | |
| Cell Boost R05.2 | HyClone | SH30584.02 | Cell Culture Supplement |
| GlucCell | CESCO Bioengineering | DG2032 | Glucose Monitoring System |
| Opti-MEM | Life Technologies | 519850.91 | Serum Free Medium for DNA transfection |
| Luria Broth (LB Media) | Life Technologies | 10855-001 | |
| GC10 Competent Cells | Sigma-Aldrich | G2919 |
Access restricted. Please log in or start a trial to view this content.